Cargando…
Therapeutic Approaches to Treat Mitochondrial Diseases: “One-Size-Fits-All” and “Precision Medicine” Strategies
Primary mitochondrial diseases (PMD) refer to a group of severe, often inherited genetic conditions due to mutations in the mitochondrial genome or in the nuclear genes encoding for proteins involved in oxidative phosphorylation (OXPHOS). The mutations hamper the last step of aerobic metabolism, aff...
Autores principales: | Bottani, Emanuela, Lamperti, Costanza, Prigione, Alessandro, Tiranti, Valeria, Persico, Nicola, Brunetti, Dario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696526/ https://www.ncbi.nlm.nih.gov/pubmed/33187380 http://dx.doi.org/10.3390/pharmaceutics12111083 |
Ejemplares similares
-
Gene Therapy for Mitochondrial Diseases: Current Status and Future Perspective
por: Di Donfrancesco, Alessia, et al.
Publicado: (2022) -
Mitochondrial diseases caused by toxic compound accumulation: from etiopathology to therapeutic approaches
por: Di Meo, Ivano, et al.
Publicado: (2015) -
Modeling mitochondrial DNA diseases: from base editing to pluripotent stem‐cell‐derived organoids
por: Tolle, Isabella, et al.
Publicado: (2023) -
Targeting Multiple Mitochondrial Processes by a Metabolic Modulator Prevents Sarcopenia and Cognitive Decline in SAMP8 Mice
por: Brunetti, Dario, et al.
Publicado: (2020) -
One size does not fit all
por: Tautz, Diethard
Publicado: (2014)